Point72 Asset Management, L.P.
Position in RLMD — Relmada Therapeutics, Inc.
CIK 1603466
STAMFORD, CT
Position in RLMD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,513,547
+$2,608,517 QoQ
Shares Held
504,820
+169.4% QoQ
Ownership
0.481%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
14 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RLMD Over Time
Shares Held
Position Value (USD)
Derivatives in RLMD
reported options exposure · as of Sep 30, 2022CallValue
$2,591,400
CallShares
70,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Point72 Asset Management, L.P. holds $2,392,275,927 across 187 Biotechnology names. RLMD ranks #88 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APLS |
Apellis Pharmaceuticals, Inc.
|
4,183,918 | $168,319,021 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
225,510 | $118,047,719 | |
| 3 | CLDX |
Celldex Therapeutics, Inc.
|
3,229,939 | $102,453,665 | |
| 4 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
846,801 | $73,646,282 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
424,750 | $71,791,245 | |
| 6 | ABVX |
Abivax S.A.
|
637,736 | $71,011,903 | |
| 7 | LEGN |
Legend Biotech Corp
|
3,886,017 | $70,298,047 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
358,634 | $67,799,757 |
All Filings in RLMD
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,513,547 | 504,820 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $905,030 | 187,377 | Shares | Defined | 2026-02-17 | |
| 2023-12-31 | $1,035,000 | 250,000 | Shares | Defined | 2024-02-14 | |
| 2023-06-30 | $11,569 | 4,703 | Shares | Defined | 2023-08-14 | |
| 2022-09-30 | $2,591,400 | 70,000 | Call | Defined | 2022-11-14 | |
| 2022-09-30 | $30,992,773 | 837,190 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $24,166,180 | 1,272,574 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $35,421,676 | 1,312,400 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $21,320,431 | 946,313 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,766,200 | 220,000 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,226,265 | 194,510 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $6,073,725 | 172,500 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $9,139,950 | 285,000 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $7,497,327 | 199,291 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $7,364,015 | 164,559 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||